HOME >> BIOLOGY >> NEWS
Keeping autoimmunity in check may depend on balance in the immune system

(PHILADELPHIA - April 16, 2002) - Scientists know that the potential to generate dangerous antibodies that attack our own cells and tissues - one of the defining characteristics of autoimmune disorders like lupus - exists in everyone. That potential is unrealized in healthy individuals, but spins out of control in those who develop disease. So, what are the factors that push the potential for producing these antibodies into action and cause autoimmunity in some individuals? A new study from researchers at The Wistar Institute suggests that health depends on maintaining a balance of normal, but countervailing processes in the immune system. New approaches to developing treatments for autoimmunity might focus on influencing this balance.

In lupus and other autoimmune diseases, antibodies against our own cells and tissues are produced by B cells. The body contains billions of B cells that can make antibodies that target infecting viruses and bacteria, but these antibodies can also include ones that can react with "self" - an immunologist's term for our own bodies. One process that normally prevents these B cells from causing harm is that their activity depends on receiving "help" from T helper cells that also become stimulated when an infection occurs. However, another kind of T cell, called a regulatory T cell, may be important in preventing T helper cells from activating B cells with the potential to generate self-reactive antibodies.

Under normal circumstances, according to the Wistar study, a critical balance may exist between T helper cells and regulatory T cells. The researchers saw that providing T helper cells to healthy mice could cause autoreactive B cells to become active, and that removing T helper cells could alleviate disease in lupus-prone mice. They also found that regulatory T cells could stop T helper cells from activating the B cells, suggesting that the presence of self-reactive T helper cells with too few regulatory T cells may be
'"/>

Contact: Franklin Hoke
hoke@wistar.upenn.edu
215-898-3716
The Wistar Institute
16-Apr-2002


Page: 1 2 3

Related biology news :

1. Keeping your peas and carrots safe to eat
2. Keeping populations of cerulean warbler healthy
3. Keeping a tight rein on cell division
4. Keeping the cold out
5. A pathway to blocking autoimmunity
6. A new hypothesis about autoimmunity. Is it possible to be too clean?
7. Sick Kids researchers pinpoint link between diabetes and nervous system autoimmunity
8. Bacterial proteins cause autoimmunity in the antiphospholipid syndrome
9. Mechanism for generating autoimmunity-suppressing cells identified
10. Atomic structure identified for gene-regulating molecule: Broad implications for cancers, autoimmunity, developmental disorders
11. Infections may trigger autoimmunity via rare, but normal process

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/7/2020)... ... 07, 2020 , ... dicentra , a leading clinical ... and dietary supplement industries, announces 2020 membership with the International Probiotics Association (“IPA”). ... pertaining to probiotics. We are thrilled to join our IPA member colleagues and ...
(Date:2/5/2020)... ... February 04, 2020 , ... Crystal Diagnostics (CDx) ... a second patent related to proprietary liquid crystal technology for rapid and accurate ... the USPTO issued on December 3, 2019. Together, these patents protect the company’s ...
(Date:1/30/2020)... , ... January 30, 2020 , ... Accelera Canada ... eye on the Canadian market, is pleased to announce that the company has opened ... since the company launched in 2017. , “We are so thrilled to now ...
Breaking Biology News(10 mins):
(Date:1/27/2020)... , ... January 27, 2020 , ... ... it has secured financing from strategic investors led by Halma plc , ... existing investors Sonion, TDF Ventures, GII LLC, and WSJ Joshua Fund. A representative ...
(Date:1/23/2020)... ... January 22, 2020 , ... Ideal Implant ... surgery industry at two recent North American investor forums specializing in medical advancements. ... Medical Technologies & Diagnostics Forum on November 21, 2019 in New York City, ...
(Date:1/22/2020)... ... 21, 2020 , ... QCDx , a private biotech company that has ... today announced the sale of the proprietary RareScope™ instrument to the Carole and Ray ... clinical cancer research. , “The RareScope can detect and isolate intact and live Circulating ...
(Date:1/8/2020)... ... 2020 , ... Anomet Products has introduced new ... in harsh environments inside or outside of the human body. , ... to achieve specific properties such as corrosion-resistance, biocompatibility, or operation at temperatures from ...
Breaking Biology Technology:
Cached News: